Mackenzie Michell-Robinson

Card image cap

75 million syringes but nothing to put in them: what is Canada’s plan for a COVID-19 vaccine?

24 July 2020 | Matthew Dankner, Mackenzie Michell-Robinson
Dankner and Michell-Robinson argue that in the current political climate, the Canadian Government must act now to invest in securing early vaccine doses from promising trials as well as make long term plans to bolster the Canadian biomedical sector in order to avoid future issues with drug development in times of international crisis.